Second-generation antipsychotics did not improve outcomes and increased costs for patients with Alzheimer disease and psychosis.
Displaying 71 - 80 of 82662
Ultrasensitive and Selective Organic FET-type Non-enzymatic Dopamine Sensor Based on Platinum Nanoparticles Decorated Reduced Graphene Oxide.
Functionally biased D2R antagonists: Targeting the β-arrestin pathway to improve antipsychotic treatment.
Chemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenics.
A revised pharmacophore model for 5-HT2A receptor antagonists derived from the atypical antipsychotic agent risperidone.
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia.
6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M1 mAChR: The Determinants of Allosteric Activity.